Moolec Science (MLEC) Cash & Equivalents (2022 - 2026)

Moolec Science has disclosed Cash & Equivalents across 5 years of filings, most recently posting $1.2 million for Q1 2026.

• Cash & Equivalents for Q1 2026 came in at $1.2 million, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $1.2 million (changed N/A YoY), and the FY2025 annual result was $767919.0, down 98.55% from the prior year.
• Cash & Equivalents came in at $1.2 million for Q1 2026 at Moolec Science, up from $1.0 million in the prior quarter.
• In the past five years, Cash & Equivalents ranged from a high of $53.0 million in Q2 2024 to a low of $767919.0 in Q2 2025.
• The 5-year median for Cash & Equivalents is $3.6 million (2024), against an average of $15.0 million.
• Across the five-year window, Cash & Equivalents jumped 1996.59% in 2024 and sank 98.55% in 2025, its largest moves.
• Moolec Science's Cash & Equivalents stood at $10.4 million in 2022, then slumped by 75.76% to $2.5 million in 2023, then surged by 1996.59% to $53.0 million in 2024, then tumbled by 98.11% to $1.0 million in 2025, then grew by 20.0% to $1.2 million in 2026.
• The last three Cash & Equivalents figures came in at $1.2 million (Q1 2026), $1.0 million (Q4 2025), and $767919.0 (Q2 2025), per Business Quant data.